Treatment of Vaginal Candidiasis in a 14-Year-Old
For a 14-year-old with vaginal candidiasis, treat with either a single 150 mg oral dose of fluconazole OR a short course (1-7 days) of topical azole therapy (clotrimazole, miconazole, or terconazole), as both achieve equivalent cure rates >90% for uncomplicated disease 1, 2.
Treatment Algorithm
First: Classify the Infection
Determine if this is uncomplicated (90% of cases) or complicated VVC 2:
Uncomplicated VVC (treat as first-line):
- Mild-to-moderate symptoms
- Sporadic occurrence (not recurrent)
- Likely Candida albicans
- Immunocompetent host
- Not pregnant
Complicated VVC (requires extended therapy):
- Severe symptoms
- Recurrent (≥4 episodes/year)
- Non-albicans species suspected
- Diabetes or immunosuppression present
- Pregnancy
Second: Choose Your Regimen
For Uncomplicated VVC (Most 14-Year-Olds):
Option 1 - Oral Therapy (Most Convenient):
- Fluconazole 150 mg single dose 1, 2
- Achieves >90% clinical cure
- Most convenient for adolescents
- No vaginal application required
Option 2 - Topical Therapy (Equally Effective):
Over-the-counter options 1:
- Clotrimazole 1% cream: 5g intravaginally daily × 7-14 days
- Miconazole 2% cream: 5g intravaginally daily × 7 days
- Miconazole 1200 mg suppository: single dose
Prescription options 1:
- Terconazole 0.8% cream: 5g intravaginally daily × 3 days
- Terconazole 80 mg suppository: one daily × 3 days
No evidence shows superiority of any one topical regimen over another 2. Oral and topical formulations achieve entirely equivalent results 2.
For Complicated VVC:
Extended therapy is required 2:
- Topical azole therapy for 7-14 days, OR
- Fluconazole 150 mg every 72 hours × 3 doses 2
For recurrent VVC (≥4 episodes/year):
- Induction: 10-14 days of topical azole or oral fluconazole
- Maintenance: Fluconazole 150 mg weekly × 6 months 2
- Achieves symptom control in >90% of patients 2
Critical Clinical Considerations
Confirm the Diagnosis First
While many adolescents and providers rely on clinical diagnosis, less than half of patients treated for VVC actually have the disease 1. Before treating:
- Perform wet mount with KOH to visualize yeast/hyphae
- Check vaginal pH (should be 4.0-4.5) 2
- If negative microscopy but high suspicion, obtain culture 2
- PCR testing has higher sensitivity (90.9%) and specificity (94.1%) than microscopy 1
Age-Specific Considerations for Adolescents
A 14-year-old is postpubertal and estrogen-sufficient, so treat as you would an adult woman 2. The single 150 mg fluconazole dose is particularly convenient for this age group and has demonstrated 86% cure rates in adolescents aged 9-18 years 3.
Common Pitfalls to Avoid
Non-albicans species (if culture-proven):
- C. glabrata: Often azole-resistant; consider boric acid 600 mg gelatin capsules intravaginally daily × 14 days or nystatin suppositories 2
- C. krusei: Responds to all topical agents but resistant to fluconazole 2
Treatment failure: If symptoms persist after initial therapy:
- Reconsider the diagnosis (bacterial vaginosis, trichomoniasis, dermatologic conditions)
- Obtain culture to identify species and consider susceptibility testing
- Extend treatment duration
- Consider non-albicans species 2, 4
What NOT to Recommend
Probiotics are not recommended for prevention or treatment of VVC 4. While some studies suggest benefit, evidence remains insufficient for guideline inclusion.
Follow-Up
No routine follow-up needed if symptoms resolve. Instruct patient to return if:
- Symptoms persist after 7 days
- Symptoms recur within 2 months
- ≥4 episodes occur within 12 months (recurrent VVC requiring maintenance therapy)